Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Autoimmune Disorders

Free Subscription 08.07.2019 1 Acta Neurol Scand 2 Ann Neurol 1 BMC Neurol 1 Curr Treat Options Neurol 1 J Autoimmun 1 J Clin Endocrinol Metab 2 J Neuroimmunol 4 J Neurol 2 J Rheumatol 2 Kidney Int 3 N Engl J Med 5 Nat Rev Neurol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Acta Neurol Scand

1. LAAKSO SM, Viitala M, Kuusisto H, Sarasoja T, et al
   Multiple sclerosis in Finland 2018- data from the national register.
   Acta Neurol Scand. 2019 Jul 4. doi: 10.1111/ane.13145.
   PubMed     Text format     Abstract available
   
   

   
   Ann Neurol

2. CREE BAC, Hauser SL
   Reply to "Silent progression or bout-onset progressive multiple sclerosis?"
   Ann Neurol. 2019 Jun 28. doi: 10.1002/ana.25536.
   PubMed     Text format    
   
   
3. GIL-PEROTIN S, Alcala C, Perez-Miralles FC, Casanova B, et al
   Silent progression or bout-onset progressive multiple sclerosis?
   Ann Neurol. 2019 Jun 28. doi: 10.1002/ana.25537.
   PubMed     Text format    
   
   

   
   BMC Neurol

4. NAKAMURA Y, Motoki M, Hirose T, Hosokawa T, et al
   Fulminant Guillain-Barre syndrome showing severe pharyngeal-cervical-brachial weakness in the recovery phase: a case report.
   BMC Neurol. 2019;19:145.
   PubMed     Text format     Abstract available
   
   

   
   Curr Treat Options Neurol

5. WOOLISCROFT L, Silbermann E, Cameron M, Bourdette D, et al
   Approaches to Remyelination Therapies in Multiple Sclerosis.
   Curr Treat Options Neurol. 2019;21:34.
   PubMed     Text format     Abstract available
   
   

   
   J Autoimmun

6. PINETON DE CHAMBRUN M, Larcher R, Pene F, Argaud L, et al
   CAPS criteria fail to identify most severely-ill thrombotic antiphospholipid syndrome patients requiring intensive care unit admission.
   J Autoimmun. 2019 Jun 25. pii: S0896-8411(19)30295.
   PubMed     Text format     Abstract available
   
   

   
   J Clin Endocrinol Metab

7. TSANG VHM, McGrath RT, Clifton-Bligh RJ, Scolyer RA, et al
   Checkpoint inhibitor associated autoimmune diabetes (CIADM) is distinct from type 1 diabetes.
   J Clin Endocrinol Metab. 2019 Jul 2. pii: 5526756. doi: 10.1210/jc.2019-00423.
   PubMed     Text format     Abstract available
   
   

   
   J Neuroimmunol

8. NICKEL M, Eid F, Jukkola P, Gu C, et al
   Copper chelation and autoimmunity differentially impact myelin in the hippocampal-prefrontal circuit.
   J Neuroimmunol. 2019;334:576998.
   PubMed     Text format     Abstract available
   
   
9. KIMURA A, Takemura M, Yamamoto Y, Hayashi Y, et al
   Cytokines and biological markers in autoimmune GFAP astrocytopathy: The potential role for pathogenesis and therapeutic implications.
   J Neuroimmunol. 2019;334:576999.
   PubMed     Text format     Abstract available
   
   

   
   J Neurol

10. SPINA E, Topa A, Iodice R, Tozza S, et al
    Six-minute walk test is reliable and sensitive in detecting response to therapy in CIDP.
    J Neurol. 2019;266:860-865.
    PubMed     Text format     Abstract available
    
    
11. BERENGUER-RUIZ L, Gimenez-Martinez J, Palazon-Bru A, Sempere AP, et al
    Relapses and obstetric outcomes in women with multiple sclerosis planning pregnancy.
    J Neurol. 2019 Jun 29. pii: 10.1007/s00415-019-09450.
    PubMed     Text format     Abstract available
    
    
12. NIJ BIJVANK JA, Balk LJ, Tan HS, Uitdehaag BM, et al
    A rare cause for visual symptoms in multiple sclerosis: posterior internuclear ophthalmoplegia of Lutz, a historical misnomer.
    J Neurol. 2017 Feb 13. doi: 10.1007/s00415-017-8412.
    PubMed     Text format    
    
    
13. MCLAUCHLAN D, Robertson NP
    B cell treatments for multiple sclerosis.
    J Neurol. 2017 Mar 4. doi: 10.1007/s00415-017-8442.
    PubMed     Text format    
    
    

    
    J Rheumatol

14. DE LUCA G, Campochiaro C, Dagna L
    Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: The Role of Endomyocardial Biopsy.
    J Rheumatol. 2019 Jul 1. pii: jrheum.190078. doi: 10.3899/jrheum.190078.
    PubMed     Text format     Abstract available
    
    
15. LI C, Zhao J, Zhao Y
    Hepatic Infarction Caused by Antiphospholipid Syndrome Secondary to Systemic Lupus Erythematosus.
    J Rheumatol. 2019;46:755-756.
    PubMed     Text format    
    
    

    
    Kidney Int

16. BARBOUR S, Djurdjev O, Gill JS, Dong JJ, et al
    A propensity score matched analysis shows no adverse effect of early steroid withdrawal in non-diabetic kidney transplant recipients with and without glomerulonephritis.
    Kidney Int. 2019 Apr 1. pii: S0085-2538(19)30388.
    PubMed     Text format     Abstract available
    
    
17. ROVIN BH, Almaani S, Malvar A
    Reimagining the kidney biopsy in the era of diagnostic biomarkers of glomerular disease.
    Kidney Int. 2019;95:265-267.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

18. RUGGENENTI P, Remuzzi G
    A First Step toward a New Approach to Treating Membranous Nephropathy.
    N Engl J Med. 2019;381:86-88.
    PubMed     Text format    
    
    
19. DEUTSCHER S
    Phage Display to Detect and Identify Autoantibodies in Disease.
    N Engl J Med. 2019;381:89-91.
    PubMed     Text format    
    
    
20. FERVENZA FC, Appel GB, Barbour SJ, Rovin BH, et al
    Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
    N Engl J Med. 2019;381:36-46.
    PubMed     Text format     Abstract available
    
    

    
    Nat Rev Neurol

21. WOOD H
    Multiple sclerosis: Latitude and vitamin D influence disease course in multiple sclerosis.
    Nat Rev Neurol. 2016 Nov 18. doi: 10.1038/nrneurol.2016.
    PubMed     Text format    
    
    
22. FYFE I
    Multiple sclerosis: New imaging marker of brain leukocyte infiltration.
    Nat Rev Neurol. 2016 Nov 25. doi: 10.1038/nrneurol.2016.
    PubMed     Text format    
    
    
23. OLSSON T, Barcellos LF, Alfredsson L
    Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis.
    Nat Rev Neurol. 2016 Dec 9. doi: 10.1038/nrneurol.2016.
    PubMed     Text format     Abstract available
    
    
24. TROJANO M, Tintore M, Montalban X, Hillert J, et al
    Treatment decisions in multiple sclerosis - insights from real-world observational studies.
    Nat Rev Neurol. 2017 Jan 13. doi: 10.1038/nrneurol.2016.
    PubMed     Text format     Abstract available
    
    
25. HEMMER B, Muhlau M
    Multiple sclerosis in 2016: Immune-directed therapies in MS - efficacy and limitations.
    Nat Rev Neurol. 2017 Jan 20. doi: 10.1038/nrneurol.2017.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: